Bolt Biotherapeutics (BOLT) Revenue (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Revenue of $5,000 for Q2 2026, down 99.7% from $1.8 million a year earlier and down 80.8% from the prior quarter.
Bolt Biotherapeutics (BOLT) Revenue (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Bolt Biotherapeutics was $4.7 million, up 12.8% year-over-year; for FY2025, it came in at $7.7 million, up 0.1% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 101.6% (FY2020 to FY2025).
- In prior years, Bolt Biotherapeutics' Revenue was $7.69 million in FY2024 (-2.4%), $7.88 million in FY2023 (+37.5%), $5.73 million in FY2022 (+354.7%) and $1.26 million in FY2021 (+445.5%).
- The Q2 2026 figure stands as the lowest quarterly Revenue in data going back to Q1 2020.
- On a year-over-year basis, Revenue increased in two of the last six quarters, with an average decline of 33.0%.
- The strongest year-over-year quarter for Revenue in the past five years was Q1 2024, with growth of 188.8%; the weakest was Q2 2026, with a decline of 99.7%.
- According to Business Quant data, Revenue for the three prior quarters was $26,000 (Q1 2026), $2.5 million (Q4 2025) and $2.17 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Bolt Biotherapeutics | 12.13 Mn | -5.97 Mn | - | 5,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 5.27 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 813,000.00 |
| Dec 31, 2021 | 508,000.00 |
| Sep 30, 2021 | 752,000.00 |
| Jun 30, 2020 | 67,000.00 |
Bolt Biotherapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BOLT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();